PTN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Palatin Technologies Inc (PTN) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the stock shows some technical bullishness, the lack of significant positive catalysts, weak financial performance, and absence of strong trading signals make it prudent to hold off on investing right now.
The technical indicators are moderately bullish with a positive MACD histogram (0.125) and bullish moving averages (SMA_5 > SMA_20 > SMA_200). RSI is neutral at 62.849, and the stock is trading near its pivot level of 21.639, with resistance at 23.343 and support at 19.936. However, the stock's historical trends suggest a higher probability of short-term declines (-0.23% next day, -0.86% next week, -2.98% next month).
Laidlaw initiated coverage with a Buy rating and a $60 price target, citing competitive advantages in melanocortin receptor-based therapeutics.
Jefferies lowered its price target to $20, citing concerns about incremental investments limiting margin expansion and AI disintermediation. The company's financials show significant losses, with a net income of -7,263,861 (up 197.40% YoY but still negative) and an EPS decline of -51.69% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress.
In 2026/Q2, revenue remained flat at 116,036 (0.00% YoY growth). Net income improved to -7,263,861 (up 197.40% YoY) but remains deeply negative. EPS dropped significantly to -2.86 (-51.69% YoY). Gross margin stayed at 100%, but overall financial performance is weak.
Analysts are mixed. Laidlaw provided a Buy rating with a $60 price target, citing competitive advantages. However, Jefferies lowered its price target to $20, citing concerns about margin expansion and AI disintermediation. The overall sentiment is cautiously optimistic but not strong enough to justify a buy.
